Hospital Italiano de Buenos Aires

Ciudad Autonoma de Buenos Aires, Buenos Aires C1199ABB

0 studies enrolling now · 5 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Amyotrophic Lateral Sclerosis, B Cell Precursor Acute Lymphoblastic Leukemia, Infectious Pneumonia, Pneumonia, Bacterial, Severe COVID-19

Studies at this site

• A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL — Running, not enrolling
• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia — Completed
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early